Persistent infection has been observed for all ehrlichial species in a variety of animals and in humans. Understanding the mechanism of persistent ehrlichial infection will enable design of new therapeutic approaches to treat ehrlichial infections and vaccines to prevent the diseases. The following hypotheses are presented: 1) persistent infection is caused by antigenic variation and/or differential expression of the outer membrane protein (OMP) genes of Ehrlichia and 2) the OMPs confer immunity in the host against re-infection by the pathogen. The subject of this proposal is Ehrlichia chaffeensis which causes a newly emerging infectious disease, human monocytotropic ehrlichiosis. Persistent infection by E. chaffeensis has been documented in human and animals. A canine model will be employed to study the mechanism of this persistent infection.
In specific aim 1, antigenic variation of E. chaffeensis gp120 will be analyzed in dogs infected by tick transmission. Canine blood will be obtained over a six month period, the gp120 gene will be amplified by PCR and sequenced and compared to the gene in the infecting isolate to determine the possible deletion or insertion of repeats in the gp120 gene. In addition, changes in the size and antigenicity of gp120 reisolated from infected canine blood will be examined.
Specific aim 2 will entail analysis of the differential expression of the p28 multigene family. This will be accomplished by RT-PCR or epitope mapping.
Aim 3 will involve testing of the protective immunity elicited in canines by immunization with recombinant OMPs, followed by challenge of immunized animals with E. chaffeensis. This will provide valuable information regarding the potential use of these antigens as subunit vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI045871-02
Application #
6497287
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Baker, Phillip J
Project Start
2001-02-01
Project End
2005-01-31
Budget Start
2002-02-01
Budget End
2003-01-31
Support Year
2
Fiscal Year
2002
Total Cost
$260,750
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Pathology
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Zhang, Jian-zhi; Popov, Vsevolod L; Gao, Si et al. (2007) The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell Microbiol 9:610-8
Zhang, Zhian; Mitchell, Douglas K; Afflerbach, Carol et al. (2006) Quantitation of human astrovirus by real-time reverse-transcription-polymerase chain reaction to examine correlation with clinical illness. J Virol Methods 134:190-6
Zhang, Jian-zhi; Sinha, Mala; Luxon, Bruce A et al. (2004) Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun 72:498-507
Zhang, Jian-zhi; Guo, Hong; Winslow, Gary M et al. (2004) Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect Immun 72:4336-43
Long, Scott Wesley; Pound, J Mathews; Yu, Xue-jie (2004) Ehrlichia prevalence in Amblyomma americanum, Central Texas. Emerg Infect Dis 10:1342-3
Zhang, Xiao-Feng; Zhang, Jian-Zhi; Long, S Wesley et al. (2003) Experimental Ehrlichia chaffeensis infection in beagles. J Med Microbiol 52:1021-6
Long, S Wesley; Zhang, Xiaofeng; Zhang, Jianzhi et al. (2003) Evaluation of transovarial transmission and transmissibility of Ehrlichia chaffeensis (Rickettsiales: Anaplasmataceae) in Amblyomma americanum (Acari: Ixodidae). J Med Entomol 40:1000-4
Zhang, Jian-zhi; McBride, Jere W; Yu, Xue-jie (2003) L-selectin and E-selectin expressed on monocytes mediating Ehrlichia chaffeensis attachment onto host cells. FEMS Microbiol Lett 227:303-9
Long, S Wesley; Zhang, Xiao-Feng; Qi, Hai et al. (2002) Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun 70:1824-31